Condition
Nephronophthisis
Total Trials
6
Recruiting
3
Active
3
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed3
Recruiting3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04874909Not ApplicableCompleted
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM)
NCT01022957Not ApplicableCompletedPrimary
Nephronophthisis : Clinical and Genetic Study
NCT06648044Not ApplicableRecruitingPrimary
Research of Therapeutic Targets in the Frame of Nephronophthisis and Renal Associated Ciliopathies
NCT01401998Recruiting
ARPKD Database Study
NCT05286632Not ApplicableCompleted
KidneYou - Innovative Digital Therapy
NCT06065852Recruiting
National Registry of Rare Kidney Diseases
Showing all 6 trials